526 related articles for article (PubMed ID: 27540687)
1. pH responsive cylindrical MSN for oral delivery of insulin-design, fabrication and evaluation.
Guha A; Biswas N; Bhattacharjee K; Sahoo N; Kuotsu K
Drug Deliv; 2016 Nov; 23(9):3552-3561. PubMed ID: 27540687
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Evaluation of pH Responsive Doxazosin Loaded Mesoporous Silica Nanoparticles: A Smart Approach in Drug Delivery.
Guha A; Biswas N; Bhattacharjee K; Das P; Kuotsu K
Curr Drug Deliv; 2016; 13(4):574-81. PubMed ID: 26201344
[TBL] [Abstract][Full Text] [Related]
3. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
4. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
Biswas N
Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
[TBL] [Abstract][Full Text] [Related]
5. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP.
Zhao Y; Trewyn BG; Slowing II; Lin VS
J Am Chem Soc; 2009 Jun; 131(24):8398-400. PubMed ID: 19476380
[TBL] [Abstract][Full Text] [Related]
7. Applications of mesoporous silica in biosensing and controlled release of insulin.
Sönmez M; Ficai D; Ficai A; Alexandrescu L; Georgescu M; Trusca R; Gurau D; Titu MA; Andronescu E
Int J Pharm; 2018 Oct; 549(1-2):179-200. PubMed ID: 30016674
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of pH-sensitive silica nanoparticles for oral-insulin delivery.
Mahkam M
Curr Drug Deliv; 2011 Nov; 8(6):607-11. PubMed ID: 21864258
[TBL] [Abstract][Full Text] [Related]
10. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
[TBL] [Abstract][Full Text] [Related]
11. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
Li P; Tan A; Prestidge CA; Nielsen HM; Müllertz A
Int J Pharm; 2014 Dec; 477(1-2):390-8. PubMed ID: 25455781
[TBL] [Abstract][Full Text] [Related]
12. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
14. pH-sensitive release of insulin-loaded mesoporous silica particles and its coordination mechanism.
Jiang F; Liu Y; Wang X; Yin Z
Eur J Pharm Sci; 2018 Jul; 119():1-12. PubMed ID: 29626595
[TBL] [Abstract][Full Text] [Related]
15. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
Zhu Y; Wang B; Chen J; He J; Qiu X
Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
[TBL] [Abstract][Full Text] [Related]
16. A pH dependent delivery of mesalazine from polymer coated and drug-loaded SBA-16 systems.
Trendafilova I; Szegedi Á; Yoncheva K; Shestakova P; Mihály J; Ristić A; Konstantinov S; Popova M
Eur J Pharm Sci; 2016 Jan; 81():75-81. PubMed ID: 26453768
[TBL] [Abstract][Full Text] [Related]
17. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a novel structure for the oral delivery of insulin and the study of its effect on diabetic rats.
Esmaeili A; Mousavi SN
Life Sci; 2017 Oct; 186():43-49. PubMed ID: 28827153
[TBL] [Abstract][Full Text] [Related]
19. Examining Insulin Adsorption onto Mesoporous Silica Microparticles for Oral Delivery.
Eilleia SY; Soliman ME; Niedermayer S; Schmidt A; Mansour S; Geneidi AS
Curr Drug Deliv; 2018; 15(4):541-553. PubMed ID: 28969564
[TBL] [Abstract][Full Text] [Related]
20. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
